Diabetic kidney disease: seven questions
Journal of the Korean Medical Association
;
: 6-13, 2020.
Article
in Korean
| WPRIM
| ID: wpr-786183
ABSTRACT
Diabetic kidney disease is a microvascular complication of diabetes mellitus and the leading cause of end-stage renal disease resulting in renal replacement therapy. Approximately 30% to 40% of diabetic patients have diabetic kidney disease, which contributes to a significant increase in morbidity and mortality. Microalbuminuria is considered the gold standard for diabetic kidney disease diagnosis; however, its predictive value is restricted. Although blood glucose control, blood pressure control, and angiotensin converting enzyme inhibitors have been the primary treatment strategies, there are no definitive treatment modalities capable of inhibiting the progression of kidney dysfunction in these patients. This study was undertaken to answer seven questions regarding the various aspects of diabetic kidney disease. Why does it develop? what kind of factors affect its development? How is it diagnosed? What are its possible biomarkers? When is a kidney biopsy necessary? What are the preventive and therapeutic options? And what are the novel treatments?
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Biopsy
/
Blood Glucose
/
Blood Pressure
/
Angiotensin-Converting Enzyme Inhibitors
/
Biomarkers
/
Mortality
/
Renal Replacement Therapy
/
Diabetes Mellitus
/
Diabetic Nephropathies
/
Diagnosis
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Medical Association
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS